Astellas Mulls Partnership With Basilea After Dropping Theravance
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma is considering a partnership with Switzerland’s Basilea Pharmaceuticals for developing antibiotics as part of a plan that could include acquiring the entire company.